Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis

Naobumi Hosogane, Kota Watanabe, Takashi Tsuji, Takeshi Miyamoto, Ken Ishii, Yasuo Niki, Masaya Nakamura, Yoshiaki Toyama, Kazuhiro Chiba, Morio Matsumoto

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.

Original languageEnglish
Pages (from-to)1249-1253
Number of pages5
JournalJournal of Orthopaedic Research
Volume30
Issue number8
DOIs
Publication statusPublished - 01-08-2012
Externally publishedYes

Fingerprint

Scoliosis
Cartilage
Biomarkers
Serum
Collagen Type II
Cartilage Oligomeric Matrix Protein
Keratan Sulfate
Hyaluronic Acid
Zygapophyseal Joint
Osteoarthritis
Collagen
Extremities
Joints

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine

Cite this

Hosogane, N., Watanabe, K., Tsuji, T., Miyamoto, T., Ishii, K., Niki, Y., ... Matsumoto, M. (2012). Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis. Journal of Orthopaedic Research, 30(8), 1249-1253. https://doi.org/10.1002/jor.22067
Hosogane, Naobumi ; Watanabe, Kota ; Tsuji, Takashi ; Miyamoto, Takeshi ; Ishii, Ken ; Niki, Yasuo ; Nakamura, Masaya ; Toyama, Yoshiaki ; Chiba, Kazuhiro ; Matsumoto, Morio. / Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis. In: Journal of Orthopaedic Research. 2012 ; Vol. 30, No. 8. pp. 1249-1253.
@article{b36912c9ad894218b9531d31d5944cdc,
title = "Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis",
abstract = "Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.",
author = "Naobumi Hosogane and Kota Watanabe and Takashi Tsuji and Takeshi Miyamoto and Ken Ishii and Yasuo Niki and Masaya Nakamura and Yoshiaki Toyama and Kazuhiro Chiba and Morio Matsumoto",
year = "2012",
month = "8",
day = "1",
doi = "10.1002/jor.22067",
language = "English",
volume = "30",
pages = "1249--1253",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

Hosogane, N, Watanabe, K, Tsuji, T, Miyamoto, T, Ishii, K, Niki, Y, Nakamura, M, Toyama, Y, Chiba, K & Matsumoto, M 2012, 'Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis', Journal of Orthopaedic Research, vol. 30, no. 8, pp. 1249-1253. https://doi.org/10.1002/jor.22067

Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis. / Hosogane, Naobumi; Watanabe, Kota; Tsuji, Takashi; Miyamoto, Takeshi; Ishii, Ken; Niki, Yasuo; Nakamura, Masaya; Toyama, Yoshiaki; Chiba, Kazuhiro; Matsumoto, Morio.

In: Journal of Orthopaedic Research, Vol. 30, No. 8, 01.08.2012, p. 1249-1253.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis

AU - Hosogane, Naobumi

AU - Watanabe, Kota

AU - Tsuji, Takashi

AU - Miyamoto, Takeshi

AU - Ishii, Ken

AU - Niki, Yasuo

AU - Nakamura, Masaya

AU - Toyama, Yoshiaki

AU - Chiba, Kazuhiro

AU - Matsumoto, Morio

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.

AB - Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.

UR - http://www.scopus.com/inward/record.url?scp=84862755173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862755173&partnerID=8YFLogxK

U2 - 10.1002/jor.22067

DO - 10.1002/jor.22067

M3 - Article

VL - 30

SP - 1249

EP - 1253

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 8

ER -